KLSE (MYR): HUMEIND (5000)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
3.32
Today's Change
+0.02 (0.61%)
Day's Change
3.25 - 3.39
Trading Volume
82,900
Market Cap
2,409 Million
NOSH
725 Million
Latest Quarter
30-Jun-2024 [#4]
Announcement Date
22-Aug-2024
Next Quarter
30-Sep-2024
Est. Ann. Date
16-Nov-2024
Est. Ann. Due Date
29-Nov-2024
QoQ | YoY
-30.42% | 4.66%
Revenue | NP to SH
1,205,222.000 | 210,939.000
RPS | P/RPS
166.13 Cent | 2.00
EPS | P/E | EY
29.08 Cent | 11.42 | 8.76%
DPS | DY | Payout %
6.58 Cent | 1.98% | 22.64%
NAPS | P/NAPS
0.73 | 4.54
QoQ | YoY
0.91% | 251.37%
NP Margin | ROE
17.50% | 39.77%
F.Y. | Ann. Date
30-Jun-2024 | 22-Aug-2024
Latest Audited Result
30-Jun-2024
Announcement Date
08-Oct-2024
Next Audited Result
30-Jun-2025
Est. Ann. Date
08-Oct-2025
Est. Ann. Due Date
27-Dec-2025
Revenue | NP to SH
1,205,222.000 | 210,939.000
RPS | P/RPS
166.13 Cent | 2.00
EPS | P/E | EY
29.08 Cent | 11.42 | 8.76%
DPS | DY | Payout %
7.22 Cent | 2.17% | 24.83%
NAPS | P/NAPS
0.73 | 4.54
YoY
251.37%
NP Margin | ROE
17.50% | 39.77%
F.Y. | Ann. Date
30-Jun-2024 | 22-Aug-2024
Revenue | NP to SH
1,205,222.000 | 210,939.000
RPS | P/RPS
166.13 Cent | 2.00
EPS | P/E | EY
29.08 Cent | 11.42 | 8.76%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
-6.08% | 251.37%
NP Margin | ROE
17.50% | 39.77%
F.Y. | Ann. Date
30-Jun-2024 | 22-Aug-2024
Last 10 FY Result | ||||||||||||||
AQR | T4Q | 30/06/24 | 30/06/23 | 30/06/22 | 30/06/21 | 30/06/20 | 30/06/19 | 30/06/18 | 30/06/17 | 30/06/16 | 30/06/15 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1,205,222 | 1,205,222 | 1,205,222 | 1,014,281 | 726,530 | 604,641 | 585,390 | 636,569 | 645,003 | 662,739 | 603,302 | 472,772 | 10.94% | |
PBT | 279,376 | 279,376 | 279,376 | 73,588 | 4,958 | -29,368 | -55,356 | -113,071 | -66,763 | 25,501 | 62,849 | 69,381 | 16.72% | |
Tax | -68,437 | -68,437 | -68,437 | -13,554 | -1,840 | 2,008 | 9,452 | 14,927 | 11,893 | -6,785 | -14,099 | -17,383 | 16.43% | |
NP | 210,939 | 210,939 | 210,939 | 60,034 | 3,118 | -27,360 | -45,904 | -98,144 | -54,870 | 18,716 | 48,750 | 51,998 | 16.81% | |
- | ||||||||||||||
NP to SH | 210,939 | 210,939 | 210,939 | 60,034 | 3,118 | -27,360 | -45,904 | -98,144 | -54,870 | 18,716 | 48,750 | 51,998 | 16.81% | |
- | ||||||||||||||
Tax Rate | 24.50% | 24.50% | 24.50% | 18.42% | 37.11% | - | - | - | - | 26.61% | 22.43% | 25.05% | - | |
Total Cost | 994,283 | 994,283 | 994,283 | 954,247 | 723,412 | 632,001 | 631,294 | 734,713 | 699,873 | 644,023 | 554,552 | 420,774 | 10.01% | |
- | ||||||||||||||
Net Worth | 530,373 | 530,373 | 530,373 | 424,972 | 366,576 | 365,585 | 397,736 | 428,024 | 388,065 | 445,557 | 435,975 | 402,438 | 3.11% |
Equity | ||||||||||||||
AQR | T4Q | 30/06/24 | 30/06/23 | 30/06/22 | 30/06/21 | 30/06/20 | 30/06/19 | 30/06/18 | 30/06/17 | 30/06/16 | 30/06/15 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Worth | 530,373 | 530,373 | 530,373 | 424,972 | 366,576 | 365,585 | 397,736 | 428,024 | 388,065 | 445,557 | 435,975 | 402,438 | 3.11% | |
NOSH | 725,484 | 725,484 | 725,484 | 509,865 | 503,627 | 500,968 | 497,284 | 491,882 | 479,093 | 479,093 | 479,093 | 479,093 | 4.71% |
Ratio Analysis | ||||||||||||||
AQR | T4Q | 30/06/24 | 30/06/23 | 30/06/22 | 30/06/21 | 30/06/20 | 30/06/19 | 30/06/18 | 30/06/17 | 30/06/16 | 30/06/15 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NP Margin | 17.50% | 17.50% | 17.50% | 5.92% | 0.43% | -4.52% | -7.84% | -15.42% | -8.51% | 2.82% | 8.08% | 11.00% | - | |
ROE | 39.77% | 39.77% | 39.77% | 14.13% | 0.85% | -7.48% | -11.54% | -22.93% | -14.14% | 4.20% | 11.18% | 12.92% | - |
Per Share | ||||||||||||||
AQR | T4Q | 30/06/24 | 30/06/23 | 30/06/22 | 30/06/21 | 30/06/20 | 30/06/19 | 30/06/18 | 30/06/17 | 30/06/16 | 30/06/15 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RPS | 184.06 | 184.06 | 184.06 | 200.48 | 144.68 | 120.73 | 117.74 | 132.36 | 134.63 | 138.33 | 125.93 | 98.68 | 7.16% | |
EPS | 36.02 | 32.22 | 36.02 | 11.91 | 0.62 | -5.48 | -9.28 | -20.26 | -11.45 | 3.91 | 10.18 | 15.17 | 10.07% | |
DPS | 8.00 | 7.29 | 8.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.00 | 3.00 | 3.00 | 11.50% | |
NAPS | 0.81 | 0.81 | 0.81 | 0.84 | 0.73 | 0.73 | 0.80 | 0.89 | 0.81 | 0.93 | 0.91 | 0.84 | -0.40% |
Adjusted Per Share Value based on latest NOSH - 725,484 | ||||||||||||||
AQR | T4Q | 30/06/24 | 30/06/23 | 30/06/22 | 30/06/21 | 30/06/20 | 30/06/19 | 30/06/18 | 30/06/17 | 30/06/16 | 30/06/15 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RPS | 166.13 | 166.13 | 166.13 | 139.81 | 100.14 | 83.34 | 80.69 | 87.74 | 88.91 | 91.35 | 83.16 | 65.17 | 10.94% | |
EPS | 29.08 | 29.08 | 29.08 | 8.28 | 0.43 | -3.77 | -6.33 | -13.53 | -7.56 | 2.58 | 6.72 | 7.17 | 16.81% | |
DPS | 7.22 | 6.58 | 7.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.32 | 1.98 | 1.98 | 15.44% | |
NAPS | 0.7311 | 0.7311 | 0.7311 | 0.5858 | 0.5053 | 0.5039 | 0.5482 | 0.59 | 0.5349 | 0.6142 | 0.6009 | 0.5547 | 3.11% |
Price Multiplier on Financial Quarter End Date | ||||||||||||||
AQR | T4Q | 30/06/24 | 30/06/23 | 30/06/22 | 30/06/21 | 30/06/20 | 30/06/19 | 30/06/18 | 30/06/17 | 30/06/16 | 30/06/15 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Date | 28/06/24 | 28/06/24 | 28/06/24 | 30/06/23 | 30/06/22 | 30/06/21 | 30/06/20 | 28/06/19 | 29/06/18 | 30/06/17 | 30/06/16 | 30/06/15 | - | |
Price | 3.35 | 3.35 | 3.35 | 1.66 | 0.96 | 1.07 | 1.08 | 1.06 | 1.08 | 2.28 | 3.10 | 3.79 | - | |
P/RPS | 1.82 | 1.82 | 1.82 | 0.83 | 0.66 | 0.89 | 0.92 | 0.80 | 0.80 | 1.65 | 2.46 | 3.84 | -7.95% | |
P/EPS | 10.40 | 10.40 | 10.40 | 13.99 | 154.61 | -19.59 | -11.70 | -5.19 | -9.43 | 58.36 | 30.47 | 34.92 | -12.58% | |
EY | 9.62 | 9.62 | 9.62 | 7.15 | 0.65 | -5.11 | -8.55 | -19.25 | -10.60 | 1.71 | 3.28 | 2.86 | 14.41% | |
DY | 2.39 | 2.18 | 2.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.88 | 0.97 | 0.79 | 13.07% | |
P/NAPS | 4.14 | 4.14 | 4.14 | 1.98 | 1.32 | 1.47 | 1.35 | 1.19 | 1.33 | 2.45 | 3.41 | 4.51 | -0.94% |
Price Multiplier on Announcement Date | ||||||||||||||
AQR | T4Q | 30/06/24 | 30/06/23 | 30/06/22 | 30/06/21 | 30/06/20 | 30/06/19 | 30/06/18 | 30/06/17 | 30/06/16 | 30/06/15 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Date | 22/08/24 | 22/08/24 | 22/08/24 | 24/08/23 | 23/08/22 | 15/09/21 | 25/08/20 | 27/08/19 | 29/08/18 | 24/08/17 | 17/08/16 | 27/08/15 | - | |
Price | 3.29 | 3.29 | 3.29 | 1.91 | 0.925 | 1.13 | 0.805 | 1.06 | 0.98 | 2.25 | 3.36 | 3.23 | - | |
P/RPS | 1.79 | 1.79 | 1.79 | 0.95 | 0.64 | 0.94 | 0.68 | 0.80 | 0.73 | 1.63 | 2.67 | 3.27 | -6.47% | |
P/EPS | 10.21 | 10.21 | 10.21 | 16.10 | 148.97 | -20.68 | -8.72 | -5.19 | -8.56 | 57.60 | 33.02 | 29.76 | -11.19% | |
EY | 9.79 | 9.79 | 9.79 | 6.21 | 0.67 | -4.83 | -11.47 | -19.25 | -11.69 | 1.74 | 3.03 | 3.36 | 12.60% | |
DY | 2.43 | 2.22 | 2.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.89 | 0.89 | 0.93 | 11.25% | |
P/NAPS | 4.06 | 4.06 | 4.06 | 2.27 | 1.27 | 1.55 | 1.01 | 1.19 | 1.21 | 2.42 | 3.69 | 3.85 | 0.59% |
PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.
NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.
Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.
All figures in '000 unless specified.
MCEMENT T4Q Result: ( EPS: 27.39, P/E: 17.96 ) price at $4.92
HUME T4Q Result: ( EPS: 27.86, P/E: 9.08 ) so, I am waiting HUME at $4.92 with pe18...
OK!!
2024-04-22 22:16
Using 4 rolling quarters, the EPS of Mcement and Humeind is 27.34 sen and 27.85 sen respectively.
In term of fair valuation, I believe EPS of Humeind is still better than Mcement.
CIMB gives a target price of Mcement at 6.80, using the same method of calculation, the fair target price of Humeind should be 6.93.
The current share price of Humeind is 3.12, there is a potential gain of 122%.
Cement stock will perform very well in the next 2 to 3 years due to MRT, LRT, ECRL, other infrastructure projects and data centers construction.
Good luck.
Thank you.
2024-05-06 16:21
MCEMENT PE 20 , HUME PE 9?
MCEMENT profit margin 10% , HUME profit margin 19.6%
It doesn't make sense
2024-05-16 10:59
HLIB can recommend Mcement, but cannot recommend Humeind.
CGS recommended Mcement the target at 6.80, but did not recommend Humeind.
So far no investment bank recommends Humeind, hence Humeind cannot perform.
I also agreed that Humeind is really undervalued.
Need to wait for Mcement result to be released, then may be Humeind can perform.
Good luck.
Thank you.
2024-05-16 11:10
Humeind will continue to break a new high because the earning of Humeind is better than Mcement in term of EPS.
The share price Humeind is chasing the share price of Mcement which is far ... far ... ahead.
Good luck.
Thank you.
----------------------------
Using 4 rolling quarters, the EPS of Mcement and Humeind is 27.34 sen and 27.85 sen respectively.
In term of fair valuation, I believe EPS of Humeind is still better than Mcement.
CIMB gives a target price of Mcement at 6.80, using the same method of calculation, the fair target price of Humeind should be 6.93.
The current share price of Humeind is 3.12, there is a potential gain of 122%.
Cement stock will perform very well in the next 2 to 3 years due to MRT, LRT, ECRL, other infrastructure projects and data centers construction.
Good luck.
Thank you.
2024-05-17 09:31
Base on current price PE still below 10, hope few week time will break 4.++
2024-05-17 11:04
Still underrated despite stellar earnings for the past few QRs and positive outlook..
2024-05-24 11:51
The Q3 2024 result of Humeind released is considered as very good if compared to Mcement.
HLIB can recommend Mcement, but cannot recommend Humeind (sister company).
CGS recommended Mcement, the target at 6.80, but did not recommend Humeind.
RHB recommended MCement, the target price at 7.15, but did not recommend Humeind.
So far no investment bank recommends Humeind, hence the share price of Humeind cannot perform.
I also agreed that Humeind is really undervalued.
The present share price at 3.40 is still considered as a cheap share if compared against Mcement.
Good luck.
Thank you.
2024-05-29 15:17
Comparing with mcement is good due to similar business lines, but to note that share price is reflective of future earnings and potential and not purely current earnings, therefore has to be seen with a pinch of salt. Hong Leong Group has its own version of high PER company as well for example MPI, with current PER of 90!!! Therefore this share price is cheap is not fully true....
2024-05-29 15:22
finally humeind getting some traction as it shd shd looking at mcement .... surprising to see that in the most recent qtr results, humeind EPS is 9.76c while mcement is only 7.72c, while former price is 3.77 while latter 5.65 ..... go figure and OTB was right
2024-07-11 13:10
JPMorgan upgrades Malaysia amid economic reforms, renewed investor confidence, data-centred investments.
Foreign money is coming back to Malaysia.
https://theedgemalaysia.com/node/718568
2024-07-11 13:29
Stock futures are little changed as Wall Street braces for Big Tech earnings
3 hours ago
•
Alex Harring
6 days ago
Time
US 30
41,962.4 42,166.2 41,916.2 -179.1 -0.43%
08:50:33
US 500
5,781.6 5,808.7 5,767.0 -32.1 -0.55%
08:51:56
US Tech 100
20,259.5 20,357.9 20,154.7 -140.3 -0.69%
08:51:05
4 days ago
TARGET PRICE RM5.10
BRIGHT OUTLOOK FOR HUME'S FY25 EARNING
The Star Tue, 29 Oct 2024
PETALING JAYA: Hume Cement Industries Bhd is expected to post robust earnings for its financial year ending June 30, 2025 (FY25), underpinned by stable demand for cement.
Despite the slower-than-expected rollout of mega infrastructure projects by the government, smaller projects such as the Penang Light Rail Transit (LRT) system and demand from the private sector could support the cement manufacturer’s growth, according to UOB Kay Hian Research (UOBKH Research).
The research house maintained its “buy” rating on Hume Cement, with a slightly lower target price of RM5.10 a share compared with RM5.40 previously.
UOBKH Research said the lower target prices was in tandem with a downgrade in its FY25 and FY26 earnings estimates for Hume Cement, primarily due to lower cement prices and lower clinker utilisation rate as a result of the slower-than-expected rollout of mega infrastructure projects.
“We anticipate cement prices will remain sustainable as construction activity is poised to increase this year. Projections indicate cement prices will, at a minimum, hold steady at RM380 per tonne,” the research house wrote in a report.
“Based on our channel checks, cement prices touched peak levels of RM400 per tonne for only four months out of a decade at pre-Covid-19 levels. However, when adjusted for inflation, the real cement price stands at RM470 per tonne, indicating room for upside from the current cement price of RM380 per tonne,” it added.
Simultaneously, coal prices, a primary input cost for cement players, are expected to fall further due to global decarbonisation initiatives, UOBKH Research said.
“That said, we expect cement players to report robust year-on-year earnings growth in FY25, supported by higher cement prices and increased output volume,” it added.
UOBKH Research noted that while there was a delayed rollout of mega infrastructure projects at the Budget 2025 presentation, two key projects were highlighted – the Johor Rapid Transit System (RTS) and Penang LRT systems.
“These projects, with a combined construction cost of RM15bil to RM16bil, are expected to be major catalysts in 2025, particularly as the Penang LRT could begin as early as next year. Given that cement typically constitutes 15% to 20% of construction costs, this translates into a potential RM2.4bil to RM3.4bil demand for cement, further boosting the cement demand outlook,” the research house said.
UOBKH Research also expected better utilisation rates with an uptick in construction activity.
“The industry is expected to grow in 2025 with utilisation rates normalising as construction activity rebounds with the acceleration of infrastructure projects and some housing projects. This will lead to stronger demand and stable prices, which will underpin improvements in the earnings outlook,” the research house said.
UOBKH Research said the company’s dividend outlook for FY25 would improve, thanks to consistently strong profits and cash flow.
Hume Cement declared a dividend per share (DPS) of eight sen in FY24, resulting a payout ratio of 27%. The recent sale of ifs Penang Prai Industrial Estate for RM39.8mil would generate a net gain of RM32.2mil, further improving the group’s debt profile.
“As a result, we expect an improved DPS outlook for 2025-2026, with a projected payout ratio of 40%. For 2025, we estimate a net DPS of 13 sen, translating to a net dividend yield of 3.8%,” UOBKH Research said.
3 days ago
nokia3310
Record results!!
2024-02-21 09:13